Was the VTEX CEO’s share sale made under a Rule 10b5-1 plan?

Yes. The Form 4 states the VTEX CEO’s sales were executed under a Rule 10b5-1 trading plan adopted on October 11, 2025. Such plans are pre-arranged programs that schedule trades in advance, helping separate routine liquidity transactions from discretionary market-timing decisions.

VTEX (NYSE: VTEX) CEO sells 4,808 shares under 10b5-1 plan

Filing Impact

(Neutral)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

VTEX Chief Executive Officer do Carmo Thomaz Junior Geraldo reported an open-market sale of 4,808 shares of Class A Common Stock at a weighted average price of $4.01 per share on March 25, 2026. The transactions were effected under a pre-arranged Rule 10b5-1 trading plan adopted on October 11, 2025.

After this sale, he holds 232,581 Class A shares directly. He is also shown with indirect ownership of 53,678 shares through Itacare Corporation and 120,089 shares through Signo Inv Tech Co Ltd, indicating a substantially larger overall stake than the shares sold in this transaction.

Insider Trade Summary 10b5-1

Net Seller: 4,808 shares ($19,280)

Net Sell 3 txns

Insider do Carmo Thomaz Junior Geraldo

Role Chief Executive Officer

Sold 4,808 shs ($19K)

Type	Security	Shares	Price	Value
Sale	Class A Common Stock	4,808	$4.01	$19K
holding	Class A Common Stock	--	--	--
holding	Class A Common Stock	--	--	--

Holdings After Transaction: Class A Common Stock — 232,581 shares (Direct); Class A Common Stock — 53,678 shares (Indirect, By Itacare Corporation)

Footnotes (1)

Represents sales effected pursuant to a 10b5-1 Plan adopted by the Reporting Person on October 11, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from USD $4.00 to USD $4.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Form 4 Insider Transactions: What Each Field Means →

03/27/2026 - 03:10 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

do Carmo Thomaz Junior Geraldo

(Last)

(First)

(Middle)

4TH FLOOR, HARBOUR PLACE

103 SOUTH CHURCH STREET

(Street)

GRAND CAYMAN

CAYMAN ISLANDS

KYI-1002

(City)

(State)

(Zip)

CAYMAN ISLANDS

(Country)

2. Issuer Name and Ticker or Trading Symbol
VTEX [ NYSE: VTEX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/25/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A Common Stock	03/25/2026		S⁽¹⁾		4,808	D	$4.01⁽²⁾	232,581	D
Class A Common Stock								53,678	I	By Itacare Corporation
Class A Common Stock								120,089	I	By Signo Inv Tech Co Ltd

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents sales effected pursuant to a 10b5-1 Plan adopted by the Reporting Person on October 11, 2025.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from USD $4.00 to USD $4.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

	/s/ Geraldo do Carmo Thomaz Junior	03/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did VTEX (VTEX) report for its CEO?

VTEX’s CEO, do Carmo Thomaz Junior Geraldo, reported an open-market sale of 4,808 Class A shares. The sale occurred on March 25, 2026 at a weighted average price of $4.01 per share and was executed under a pre-arranged Rule 10b5-1 trading plan.

How many VTEX shares did the CEO sell and at what price?

The VTEX CEO sold 4,808 shares of Class A Common Stock at a weighted average price of $4.01. The filing notes multiple trades occurred within a price range from $4.00 to $4.01, and detailed trade-level information is available on request from the company or regulators.

How many VTEX shares does the CEO hold after the reported sale?

Following the March 25, 2026 sale, the VTEX CEO holds 232,581 Class A shares directly. The Form 4 also reports indirect holdings of 53,678 shares through Itacare Corporation and 120,089 shares through Signo Inv Tech Co Ltd, reflecting additional ownership beyond his direct position.

What indirect VTEX shareholdings are associated with the CEO?

The Form 4 lists two indirect VTEX positions for the CEO: 53,678 Class A shares held by Itacare Corporation and 120,089 Class A shares held by Signo Inv Tech Co Ltd. These are reported as indirect ownership interests in addition to his personal direct holdings of 232,581 shares.

Does the VTEX CEO’s Form 4 show any options or derivative exercises?

No derivative transactions are shown in this Form 4. The derivative summary is empty and the only reported trade is an open-market sale of non-derivative Class A Common Stock, indicating no option exercises or conversions were reported in this particular filing.